• English
  • Français
  • Русский

News

Insulinagypt توافر مستحضر انسوليناجيبت

يسر شركة المهن الطبية للأدوية أن تعلن عن توافر مستحضر أنسوليناجيبت أنسولين بشرى Insulinagypt 70/30 vials- 10ml ,4 ml Insulinagypt R vials- 10ml ,4 ml Insulinagypt N vials -10ml ,4 ml :لمزيد من المعلومات يسعدنا التواصل علي التليفونات الاتية 01020044999 - 01020044888

MUP Tech successfully launched Insulinagypt vial in Egyptian market

MUP successfully launched the first Egyptian human insulin vial with American Standard and international technology produced from (MUP- TECH) Factory and with the brand name Insulinagypt.

MUP recently acquired human insulin (Vial) factory of American company Eli Lilly and Company in the sixth of October, which is one of the five factories for the production of human insulin owned by Eli Lilly worldwide and changed the name of the factory to (MUP- TECH).

New Vacancies at MUP.Tech

MUP & Eli-Lilly-USA signed three agreements On December 21, 2014

According to the Memorandum of the Understanding signed on November 4, 2014 Between MUP & Eli- Lilly under the patronage of the Minister of Health and population of Egypt. On December 21, 2014 MUP & Eli-Lilly –USA signed three agreements: First agreement "Factory Purchase agreement" concerning MUP acquiring of Eli-Lilly factory which produce human Insulin vials, located in 6th October City , Egypt. Production planed to be in the Egyptian market within weeks.

شركه المهن الطبيه للأدويه تستعد لانتاج عقار سوفالدى لعلاج مرضي الكبد

5 شركات مصرية لإنتاج الدواء الأمريكى لعلاج فيروس "سى"

وزير الصحة يختار الشركات بدون مناقصة ويستثنيها بشرط الالتزام بالتصنيع خلال 6 أشهر

علمت "المصرى اليوم " أن وزارة الصحة اختارت 5 شركات لإنتاج الدواء الأمريكى "سوفالدى" لعلاج التهاب الكبد الوبائى "فيروس سى" بدون إجراء مناقصة. كما تم إعفاء الشركات من العدد المحدد داخل صندوق المثائل للعقار.

Medical Union Pharmaceuticals (MUP) Prepares to acquire Lilly manufacturing plant in Egypt

Companies sign memorandum of understanding for acquisition of human insulin vials manufacturing plant in Cairo, Egypt under the patronage of the Ministry of Health and population of Egypt

Egypt (Nov 5, 2014)- Eli Lilly and company and Medical Union Pharmaceuticals (MUP), a subsidiary of ACDIMA, announced today that the companies have signed a non-binding memorandum of understanding for MUP’s acquisition of Lilly’s human insulin vials manufacturing plant located in the 6th of October city , Egypt. The deal is expected to be finalized during 2015.

المهن الطبية للأدوية تستعد لشراء مصنع ليللى فى مصر

وقعت الشركتان وبرعاية وزارة الصحة والسكان مذكرة تفاهم لشراء شركة المهن الطبية للأدوية مصنع فيال الإنسولين البشرى لليللى فى القاهرة, مصر

 

مقال السيد الدكتور العضو المنتدب لجريدة فارما تايم

Medical Union Pharmaceuticals newsletter

Subscribe with your e-mail address to stay up-to-date. We will send you all new MUP news, product launches, Pharmacovigilance cases and our activity to be up-to-date

Go to top